Genmab
GMAB
#746
Rank
NZ$57.03 B
Marketcap
NZ$92.50
Share price
-1.46%
Change (1 day)
70.57%
Change (1 year)

EPS for Genmab (GMAB)

EPS in 2026 (TTM): NZ$3.13

According to Genmab's latest financial reports the company's current EPS (TTM) is NZ$3.27. In 2025 the company made an earnings per share (EPS) of NZ$2.83 a decrease over its 2024 EPS that were of NZ$3.12.

EPS history for Genmab from 2002 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$3.1310.46%
2025NZ$2.83-9.09%
2024NZ$3.1276.32%
2023NZ$1.77-20.44%
2022NZ$2.2273.57%
2021NZ$1.28-41.96%
2020NZ$2.21133.96%
2019NZ$0.9440.1%
2018NZ$0.6725.93%
2017NZ$0.534.18%
2016NZ$0.5146.79%
2015NZ$0.35118.84%
2014NZ$0.16114.51%
2013NZ$0.07444-121.72%
2012NZ-$0.34-19.1%
2011NZ-$0.4281.46%
2010NZ-$0.23-70.53%
2009NZ-$0.797.24%
2008NZ-$0.74137.03%
2007NZ-$0.31-14.43%
2006NZ-$0.36-0.22%
2005NZ-$0.37-30.15%
2004NZ-$0.5217.97%
2003NZ-$0.44-20.22%
2002NZ-$0.56